US2006248605A1PendingUtilityA1

Beta-amyloid peptide-binding proteins and polynucleotides encoding the same

Assignee: WYETH CORPPriority: Apr 16, 1997Filed: Jul 12, 2006Published: Nov 2, 2006
Est. expiryApr 16, 2017(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/28A01K 2227/105C07K 2319/00A01K 2217/05C07K 14/47A01K 2217/075C07K 14/4711A61K 38/00A01K 67/0275
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel proteins which bind human β-amyloid peptide, polynucleotides which encode these proteins, and methods for producing these proteins are provided. Diagnostic, therapeutic, and screening methods employing the polynucleotides and polypeptides of the present invention are also provided. Transgenic animals and knockout animals are also provided.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled)  
     
     
         21 . An antibody or fragment thereof that binds specifically to the polypeptide of SEQ ID NO: 2.  
     
     
         22 . The antibody or fragment thereof of  claim 21 , wherein the antibody or fragment thereof is monoclonal.  
     
     
         23 . The antibody or fragment thereof of  claim 21 , wherein the antibody or fragment thereof is a single chain.  
     
     
         24 . A method of detecting the presence or quantity of β-amyloid peptide-binding protein in a sample, the method comprising the steps of: 
 a) contacting the sample with the antibody of  claim 21 , thereby forming a complex; and    b) determining the presence or quantity of the complex.    
     
     
         25 . A method of inhibiting the polypeptide of SEQ ID NO: 2, the method comprising the step of combining the antibody or fragment thereof of  claim 21  with a sample that contains the polypeptide of SEQ ID NO: 2.  
     
     
         26 . A method of making an antibody or fragment thereof, the method comprising the step of culturing a cell line that expresses the antibody or fragment thereof of  claim 21 .  
     
     
         27 . A method of treating a patient, the method comprising the step of administering to the patient a therapeutically effective quantity of the antibody or fragment thereof of  claim 21 .  
     
     
         28 . The method of  claim 27  wherein the antibody or fragment thereof inhibits the polypeptide of SEQ ID NO: 2.  
     
     
         29 . The method of  claim 27  wherein the antibody or fragment thereof inhibits interaction of the polypeptide of SEQ ID NO: 2 with β-amyloid peptide.

Join the waitlist — get patent alerts

Track US2006248605A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.